2014
DOI: 10.2967/jnumed.114.139683
|View full text |Cite
|
Sign up to set email alerts
|

SNMMI Comment on ASCO 2013 “Choosing Wisely” Recommendation on Use of PET/CT in Recurrent Cancer Surveillance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
(5 reference statements)
0
1
0
Order By: Relevance
“…Only a limited number of studies regarding surveillance FDG PET are available in patients treated for ovarian cancer, and the diagnostic performance of post-treatment FDG PET has not been satisfactory for the detection of recurrence or persistent diseases [12,13]. However, several recent studies in other malignancies have demonstrated that FDG PET/CT has strong potential for post-treatment surveillance [14][15][16].…”
Section: Introductionmentioning
confidence: 96%
“…Only a limited number of studies regarding surveillance FDG PET are available in patients treated for ovarian cancer, and the diagnostic performance of post-treatment FDG PET has not been satisfactory for the detection of recurrence or persistent diseases [12,13]. However, several recent studies in other malignancies have demonstrated that FDG PET/CT has strong potential for post-treatment surveillance [14][15][16].…”
Section: Introductionmentioning
confidence: 96%